Acknowledgement
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science and ICT) (No. 2019R1I1A2A01045132), Republic of Korea.
References
- R. Ganceviciene, A. I. Liakou, A. Theodoridis, E. Makrantonaki, and C. C. Zouboulis, Skin anti-aging strategies, Dermatoendocrinol., 4(3), 308 (2012). https://doi.org/10.4161/derm.22804
- M. Ramos-e-Silva, L. R. Celem, S. Ramos-e-Silva, and A. P. Fucci-da-Costa, Anti-aging cosmetics: Facts and controversies, Clin. Dermatol., 31(6), 750 (2013). https://doi.org/10.1016/j.clindermatol.2013.05.013
- P. T. Rose, Pigmentary disorders, Med. Clin. North. Am., 93(6), 1225 (2009). https://doi.org/10.1016/j.mcna.2009.08.005
- V. D. Callender, S. St Surin-Lord, E. C. Davis, and M. Maclin, Postinflammatory hyperpigmentation: etiologic and therapeutic considerations, Am. J. Clin. Dermatol., 12(2), 87 (2011). https://doi.org/10.2165/11536930-000000000-00000
- P. Ganju, S. Nagpal, M. H. Mohammed, P. Nishal Kumar, R. Pandey, V. T. Natarajan, S. S. Mande, and R. S. Gokhale, Microbial community profiling shows dysbiosis in the lesional skin of vitiligo subjects, Sci. Rep., 6, 18761 (2016). https://doi.org/10.1038/srep18761
- R. A. Spritz and G. H. Andersen, Genetics of vitiligo, Dermatol. Clin., 35(2), 245 (2017). https://doi.org/10.1016/j.det.2016.11.013
- M. B. C. Maymone, H. H. Neamah, E. A. Secemsky, and N. A. Vashi, Correlating the dermatology life quality index and skin discoloration impact evaluation questionnaire tools in disorders of hyperpigmentation, J. Dermatol., 45(3), 361 (2018). https://doi.org/10.1111/1346-8138.14172
- J. D. Simon, D. Peles, K. Wakamatsu, and S. Ito, Current challenges in understanding melanogenesis: bridging chemistry, biological control, morphology, and function, Pigment Cell Melanoma Res., 22(5), 563 (2009). https://doi.org/10.1111/j.1755-148X.2009.00610.x
- C. Olivares and F. Solano, New insights into the active site structure and catalytic mechanism of tyrosinase and its related proteins, Pigment Cell Melanoma Res., 22(6), 750 (2009). https://doi.org/10.1111/j.1755-148X.2009.00636.x
- M. V. Schiaffino, Signaling pathways in melanosome biogenesis and pathology, Int. J. Biochem. Cell Biol., 42(7), 1094 (2010). https://doi.org/10.1016/j.biocel.2010.03.023
- A. Slominski, D. J. Tobin, S. Shibahara, and J. Wortsman, Melanin pigmentation in mammalian skin and its hormonal regulation, Physiol. Rev., 84(4), 1155 (2004). https://doi.org/10.1152/physrev.00044.2003
- Y. C. Boo, Up- or downregulation of melanin synthesis using amino acids, peptides, and their analogs, Biomedicines, 8(9), 322 (2020). https://doi.org/10.3390/biomedicines8090322
- Y. C. Boo, Human skin lightening efficacy of resveratrol and its analogs: from in vitro studies to cosmetic applications, Antioxidants, 8(9), 332 (2019). https://doi.org/10.3390/antiox8090332
- Y. C. Boo, p-coumaric acid as an active ingredient in cosmetics: a review focusing on its antimelanogenic effects, Antioxidants, 8(8), 275 (2019). https://doi.org/10.3390/antiox8080275
- C. Niu and H. A. Aisa, Upregulation of melanogenesis and tyrosinase activity: potential agents for vitiligo, Molecules, 22(8), 1303 (2017). https://doi.org/10.3390/molecules22081303
- T. Pillaiyar, V. Namasivayam, M. Manickam, and S. H. Jung, Inhibitors of melanogenesis: an updated review, J. Med. Chem., 61(17), 7395 (2018). https://doi.org/10.1021/acs.jmedchem.7b00967
- Y. C. Boo, Emerging strategies to protect the skin from ultraviolet rays using plant-derived materials, Antioxidants, 9(7), 637 (2020). https://doi.org/10.3390/antiox9070637
- K. D. Haltaufderhyde and E. Oancea, Genome-wide transcriptome analysis of human epidermal melanocytes, Genomics, 104(6 Pt B), 482 (2014). https://doi.org/10.1016/j.ygeno.2014.09.010
- M. Soejima and Y. Koda, Population differences of two coding SNPs in pigmentation-related genes SLC24A5 and SLC45A2, Int. J. Legal Med., 121(1), 36 (2007). https://doi.org/10.1007/s00414-006-0112-z
- J. B. Cheng and R. J. Cho, Genetics and epigenetics of the skin meet deep sequence, J. Invest. Dermatol., 132(3 Pt 2), 923 (2012). https://doi.org/10.1038/jid.2011.436
- J. S. Shin, H. S. Jeong, M. K. Kim, H. Y. Yun, K. J. Baek, N. S. Kwon, and D. S. Kim, The DNA methylation inhibitor 5-azacytidine decreases melanin synthesis by inhibiting CREB phosphorylation, Pharmazie, 70(10), 646 (2015).
- S. Yokoyama, E. Feige, L. L. Poling, C. Levy, H. R. Widlund, M. Khaled, A. L. Kung, and D. E. Fisher, Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage, Pigment Cell Melanoma Res., 21(4), 457 (2008). https://doi.org/10.1111/j.1755-148X.2008.00480.x
- K. H. Kim, B. H. Bin, J. Kim, S. E. Dong, P. J. Park, H. Choi, B. J. Kim, S. J. Yu, H. Kang, H. H. Kang, E. G. Cho, and T. R. Lee, Novel inhibitory function of miR-125b in melanogenesis, Pigment Cell Melanoma Res., 27(1), 140 (2014). https://doi.org/10.1111/pcmr.12179
- K. H. Kim, T. R. Lee, and E. G. Cho, SH3BP4, a novel pigmentation gene, is inversely regulated by miR-125b and MITF, Exp. Mol. Med., 49(8), e367 (2017). https://doi.org/10.1038/emm.2017.115
- H . Song, Y. J. Hwang, J. W. Ha, and Y. C. Boo, Screening of an epigenetic drug library identifies 4-((hydroxyamino) carbonyl)-N-(2-hydroxyethyl)-N-phenyl -benzeneacetamide that reduces melanin synthesis by inhibiting tyrosinase activity independently of epigenetic mechanisms, Int. J. Mol. Sci., 21(13), 4589 (2020). https://doi.org/10.3390/ijms21134589
- R. I. Glazer, K. D. Hartman, M. C. Knode, M. M. Richard, P. K. Chiang, C. K. Tseng, and V. E. Marquez, 3-Deazaneplanocin: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60, Biochem. Biophys. Res. Commun., 135(2), 688 (1986). https://doi.org/10.1016/0006-291X(86)90048-3
- J. Selhub, Homocysteine metabolism, Annu. Rev. Nutr., 19, 217 (1999). https://doi.org/10.1146/annurev.nutr.19.1.217
- J. K. Seok, S. W. Lee, J. Choi, Y. M. Kim, and Y. C. Boo, Identification of novel antimelanogenic hexapeptides via positional scanning of a synthetic peptide combinatorial library, Exp. Dermatol., 26(8), 742 (2017). https://doi.org/10.1111/exd.13262
- J. H. Kim, J. K. Seok, Y. M. Kim, and Y. C. Boo, Identification of small peptides and glycinamide that inhibit melanin synthesis using a positional scanning synthetic peptide combinatorial library, Br. J. Dermatol., 181(1), 128 (2019). https://doi.org/10.1111/bjd.17634
- S. A. Altman, L. Randers, and G. Rao, Comparison of trypan blue-dye exclusion and fluorometric assays for mammalian-cell viability determinations, Biotechnol. Prog., 9(6), 671 (1993). https://doi.org/10.1021/bp00024a017
- A. Garcia-Jimenez, J. A. Teruel-Puche, J. Berna, J. N. Rodriguez-Lopez, J. Tudela, and F. Garcia-Canovas, Action of tyrosinase on alpha and beta-arbutin: A kinetic study, PLoS One, 12(5), e0177330 (2017). https://doi.org/10.1371/journal.pone.0177330
- S. W. Lee, J. H. Kim, H. Song, J. K. Seok, S. S. Hong, and Y. C. Boo, Luteolin 7-sulfate attenuates melanin synthesis through inhibition of CREB- and MITF-mediated tyrosinase expression, Antioxidants, 8(4), 87 (2019). https://doi.org/10.3390/antiox8040087
- S. M. An, J. S. Koh, and Y. C. Boo, Inhibition of melanogenesis by tyrosinase siRNA in human melanocytes, BMB Rep., 42(3), 178 (2009). https://doi.org/10.5483/BMBRep.2009.42.3.178
- R. Yang, Y. Zheng, L. Li, S. Liu, M. Burrows, Z. Wei, A. Nace, M. Herlyn, R. Cui, W. Guo, G. Cotsarelis, and X. Xu, Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors, Nat. Commun., 5, 5807 (2014). https://doi.org/10.1038/ncomms6807
- G. Y. Seo, Y. Ha, A. H. Park, O. W. Kwon, and Y. J. Kim, Leathesia difformis extract inhibits alpha-MSH-induced melanogenesis in B16F10 cells via down-regulation of CREB signaling pathway, Int. J. Mol. Sci., 20(3), 536 (2019). https://doi.org/10.3390/ijms20030536
- M. S. H an, X. Che, G. H . Cho, H . R. Park, K. E. Lim, N. R. Park, J. S. Jin, Y. K. Jung, J. H. Jeong, I. K. Lee, S. Kato, and J. Y. Choi, Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification, Plos One, 8(12), e83584 (2013). https://doi.org/10.1371/journal.pone.0083584
- K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method, Methods, 25(4), 402 (2001). https://doi.org/10.1006/meth.2001.1262
- K. B. Seamon, W. Padgett, and J. W. Daly, Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells, Proc. Natl. Acad. Sci. U S A, 78(6), 3363 (1981). https://doi.org/10.1073/pnas.78.6.3363
- J. A. D'Orazio, T. Nobuhisa, R. Cui, M. Arya, M. Spry, K. Wakamatsu, V. Igras, T. Kunisada, S. R. Granter, E. K. Nishimura, S. Ito, and D. E. Fisher, Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning, Nature, 443(7109), 340 (2006). https://doi.org/10.1038/nature05098
- T. B. Miranda, C. C. Cortez, C. B. Yoo, G. N. Liang, M. Abe, T. K. Kelly, V. E. Marquez, and P. A. Jones, DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation, Mol. Cancer Ther., 8(6), 1579 (2009). https://doi.org/10.1158/1535-7163.MCT-09-0013
- A. Hayden, P. W. M. Johnson, G. Packham, and S. J. Crabb, S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition, Breast Cancer Res. Treat., 127(1), 109 (2011). https://doi.org/10.1007/s10549-010-0982-0
- F. Liu, D. Barsyte-Lovejoy, F. L. Li, Y. Xiong, V. Korboukh, X. P. Huang, A. Allali-Hassani, W. P. Janzen, B. L. Roth, S. V. Frye, C. H. Arrowsmith, P. J. Brown, M. Vedadi, and J. Jin, Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP, J. Med. Chem., 56(21), 8931 (2013). https://doi.org/10.1021/jm401480r
- Z. Y. Lu, H . R. Salwen, J. U. Raj, and Q. W. Yang, Histone lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, and DNA methylation of human neuroblastoma cells, Cancer Res., 72((2012).
- R. Dey-Rao and A. A. Sinha, Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo, Genes Immun., 17(1), 30 (2016). https://doi.org/10.1038/gene.2015.48
- S. Singh, U. Singh, and S. S. Pandey, Increased level of serum homocysteine in vitiligo, J. Clin. Lab. Anal., 25(2), 110 (2011). https://doi.org/10.1002/jcla.20442
- J. Silverberg, and N. Silverberg, Serum homocysteine is associated with extent of vitiligo vulgaris, J. Am. Acad. Dermatol., 64(2), Ab142 (2011).
- T. Y. Tsai, C. Y. Kuo, and Y. C. Huang, Serum homocysteine, folate, and vitamin B-12 levels in patients with vitiligo and their potential roles as disease activity biomarkers: A systematic review and meta-analysis, J. Am. Acad. Dermatol., 80(3), 646 (2019). https://doi.org/10.1016/j.jaad.2018.08.029
- J. Chen, T. Zhuang, J. Chen, Y. Tian, X. Yi, Q. Ni, W. Zhang, P. Song, Z. Jian, L. Liu, T. Cui, K. Li, T. Gao, C. Li, and S. Li, Homocysteine induces melanocytes apoptosis via PERK-eIF2alpha-CHOP pathway in vitiligo, Clin. Sci. (Lond), 134(10), 1127 (2020). https://doi.org/10.1042/cs20200218
- O. Reish, D. Townsend, S. A. Berry, M. Y. Tsai, and R. A. King, Tyrosinase inhibition due to interaction of homocysteine with copper - the mechanism for reversible hypopigmentation in homocystinuria due to cystathionine beta-synthase deficiency, Am. J. Hum. Genet., 57(1), 127 (1995).